Lixte Biotechnology Holdings, Inc.
LIXT
$5.16
$0.122.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 391.52% | 76.35% | -65.81% | -59.44% | -75.28% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -32.93% | 77.97% | 41.57% | 33.64% | 293.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 352.06% | 221.71% | -62.90% | -57.81% | -73.41% |
|
|
|||||
| Total Current Assets | 352.06% | 221.71% | -62.90% | -57.81% | -73.41% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,011.62% | 220.40% | -55.44% | -57.81% | -73.41% |
|
|
|||||
| Total Accounts Payable | 457.45% | 69.96% | -37.52% | -45.89% | -53.78% |
| Total Accrued Expenses | 358.18% | -- | -- | -- | -24.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 28.12% | 11.48% | 53.40% | 12.26% | 49.65% |
| Total Other Current Liabilities | 28.12% | 11.48% | 53.40% | 12.26% | 49.65% |
| Total Current Liabilities | 318.82% | 58.48% | 27.43% | -23.27% | 1.40% |
|
|
|||||
| Total Current Liabilities | 318.82% | 58.48% | 27.43% | -23.27% | 1.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 456.74% | 58.48% | 27.43% | -23.27% | 1.40% |
|
|
|||||
| Common Stock & APIC | 33.64% | 17.39% | 10.15% | 2.76% | 0.85% |
| Retained Earnings | -11.54% | -7.94% | -6.12% | -6.72% | -7.40% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 396.79% | 210.59% | 151.96% | -526.58% | -640.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -50.53% | -27.05% | -- | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -50.53% | -27.05% | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 396.79% | 210.59% | 151.96% | -526.58% | -640.18% |
| Total Preferred Equity | -50.53% | -27.05% | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,225.15% | 259.38% | -70.99% | -62.93% | -79.29% |
|
|
|||||